Dr. Gerald Diaz @GeraldMD
23.4M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
18 results
treatment hivaids opportunistic prevention medications drugs mycobacterium table adjunct antibiotics antiil6 aviumcomplex bartonella bartonellosis capsulatum cdiff cdifficile chagas clostridium cmv
COVID-19: ICU Guidelines for the Non-Intensivist Infection Control Risk Factors for Severe Disease Initial Laboratory Workup COVID-19 Specific Medications Respiratory Cardiac Hematologic Neuro/Sedation #COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... -19 Specific Medications ... #criticalcare #Guidelines ... NonIntensivist #diagnosis #management
Drugs Used for the Treatment of COVID-19 Infection LOPINAVIR / RITONAVIR INTERFERON Beta-I REMDESIVIR HYDROXYCHLOROQUINE TOCILIZUMAB Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... -19 Infection LOPINAVIR ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Prophylaxis) Indication ... Penicilliosis #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... -19 Infection ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19 IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe COVID ... respiratory tract infection ... #Pharmacology # ... Management #Medications
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile infection ... Episode #Pharmacology ... #Management #CDiff
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
IDSA Recommendations ... Clinical Disease Indication ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... Leishmaniasis Indication ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
IDSA Recommendations ... Encephalitis in HIV-AIDS Indications ... opportunistic #infections ... #HIVAIDS #management ... pharmacology
Isolation vs Quarantine - What's the Difference? Isolation: • Used for: People with confirmed or suspected COVID-19
confirmed or suspected COVID ... the person from infecting ... Quarantine #comparison #indications ... #Difference #coronavirus ... #covid19 #management
empty